Flu Fighters
Drug firms help battle the novel H1N1 virus in response to calls from health agencies and governments
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
September 28, 2009 Cover
Volume 87, Issue 39
Drug firms help battle the novel H1N1 virus in response to calls from health agencies and governments
Credit:
Drug firms help battle the novel H1N1 virus in response to calls from health agencies and governments
Investment flows into the U.S. as drugmakers reassess their supply chains
Advances in breeding and basic science confer drought tolerance to crops
Unique challenges face developers of drugs that hit disease-related RNAs rather than disease-related proteins
Small-molecule drugs to treat dry age-related macular degeneration are heading to the clinic
Makers of brand-name biologics get closer to winning 12 years of exclusivity before generic versions can come to market
Technology and Business news for the laboratory world